Patients with end-stage interstitial lung disease may have more problems with dyspnea than end-stage lung cancer patients

Indian Journal of Palliative Care

Volumn 22, Issue 3, 2016, Pages 282-287

  Matsunuma, Ryo ^a   Takato, Hazuki ^b   Takeda, Yoshihiro ^a   Watanabe, Satoshi ^b   Waseda, Yuko ^c   Murakami, Shinya ^a   Kawaura, Yukimitsu ^a   Kasahara, Kazuo ^a  

^a Komatsu Municipal Hospital   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c Japan Community Health Care Organization Kanazawa Hospital   (Japan)

Author keywords

Dyspnea; Interstitial lung disease; Morphine; Palliative care

Indexed keywords

EID: 84978139640     PISSN: 09731075     EISSN: 19983735     Source Type: Journal    
DOI: 10.4103/0973-1075.185035     Document Type: Article

References (37)

1. King TE Jr., Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-81
2. Bjoraker JA, Ryu JH, Edwin MK, Myers JL, Tazelaar HD, Schroeder DR, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199-203
3. Daniil ZD, Gilchrist FC, Nicholson AG, Hansell DM, Harris J, Colby TV, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899-905
4. Ohno S, Nakaya T, Bando M, Sugiyama Y. Nationwide epidemiological survey of patients with idiopathic interstitial pneumonias using clinical personal records. Nihon Kokyuki Gakkai Zasshi 2007;45:759-65
5. Arita K, Mito A, Kajihara T, Nitta T, Ikegami Y, Awaya K, et al. Studies of palliative care for pulmonary fibrosis and interstitial pneumonia at the end-of-life over the last 20 years. Jpn J Chest Dis 2010;69:354-61
6. Arita K, Daido K, Ejima T, Imaoka N. A study of clinical features of patients with end-stage pulmonary fibrosis under home oxygen therapy. Respir Res 1995;14:868-73
7. Sugiyama Y, Takahashi H, Ebina M, Bando M, Suzuki E, Inase N, et al. Idiopathic Interstitial Pneumonias: Diagnosis and Treatment. 2nd ed. Tokyo: Nankodo; 2011
8. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824
9. Hirani N, Burge G, Copley S, Duck A, Harrison NK, Hippard M, et al. National Institute for Health and Care Excellence (NICE). The diagnosis and management of suspected Idiopathic pulmonary fibrosis. Manchester: National Institute for Health and Care Excellence; 2013
10. Traue DC, Ross JR. Palliative care in non-malignant diseases. J R Soc Med 2005;98:503-6
11. Addington-Hall J. Reaching out: Specialist palliative care for adults with non-malignant disease. London: National Council for Hospices and Specialist Palliative Care Services; 1995
12. National Hospice and Palliative Care Organization (NHPCO). NHPCO facts and figures: Hospice care in America 2012 edition [Internet]. Alexandria VA National Hospice and Palliative Care Organization; 2012 Oct. Available from: http://www.nhpco.org/sites/default/files/public/ Statistics-Research/2012-Facts-Figures.pdf. [Cited on 2012 Oct]
13. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304
14. Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-48
15. Ohta T, Waga S, Handa W, Saito I, Takeuchi K. New grading of level of disordered consiousness (author's transl). No Shinkei Geka 1974;2:623-7
16. Bajwah S, Higginson IJ, Ross JR, Wells AU, Birring SS, Patel A, et al. Specialist palliative care is more than drugs: A retrospective study of ILD patients. Lung 2012;190:215-20
17. Buss MK. Palliating Dyspnea for Patients with Cancer. Available from: http://www.meetinglibrary.asco.org/sites/meetinglibrary.asco.org/files/ Educational%20Book/PDF%20Files/2009/09edbk.patientcare. 03.pdf. [Last accessed on 2005 Jan 30]
18. Sakamoto S, Homma S, Miyamoto A, Kurosaki A, Fujii T, Yoshimura K. Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 2010;49:109-15
19. Ding J, Chen Z, Feng K. Procalcitonin-guided antibiotic use in acute exacerbations of idiopathic pulmonary fibrosis. Int J Med Sci 2013;10:903-7
20. Lee KS, Higgins MJ, Patel BM, Larson JS, Rady MY. Paraneoplastic coma and acquired central alveolar hypoventilation as a manifestation of brainstem encephalitis in a patient with ANNA-1 antibody and small-cell lung cancer. Neurocrit Care 2006;4:137-9
21. Sugimoto Y, Semba H, Fujii S, Furukawa E, Kurano R, Kase S. Clinical analysis of meningeal carcinomatosis associated with primary lung cancer: Significance of intrathecal chemotherapy. Jpn J Lung Cancer 2008;48:688-92
22. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 2005;352:373-9
23. Raftopoulos H. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer 2007;15:1341-7
24. Ishikawa H, Teramoto N. Loss of consciousness in elderly patients. Geriatr Med 2013;51:803-6
25. Cobb JL, Glantz MJ, Nicholas PK, Martin EW, Paul-Simon A, Cole BF, et al. Delirium in patients with cancer at the end of life. Cancer Pract 2000;8:172-7
26. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002;57:939-44
27. Ahmedzai S. Palliaton of respiratory symptoms. Oxford Textbook of Palliative Medicine. New York: Oxford University Press; 1998. p. 583-616
28. Mazzocato C, Buclin T, Rapin CH. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized double-blind controlled trial. Ann Oncol 1999;10:1511-4
29. Gamborg H, Riis J, Christrup L, Krantz T. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases. J Opioid Manag 2013;9:269-74
30. Allen S, Raut S, Woollard J, Vassallo M. Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliat Med 2005;19:128-30
31. Harris-Eze AO, Sridhar G, Clemens RE, Zintel TA, Gallagher CG, Marciniuk DD. Low-dose nebulized morphine does not improve exercise in interstitial lung disease. Am J Respir Crit Care Med 1995;152(6 Pt 1):1940-5
32. Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage 2006;31:38-47
33. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 2010; (1):CD007354
34. Disayabutr S, Calfee CS, Collard HR, Wolters PJ. Interstitial lung diseases in the hospitalized patient. BMC Med 2015;13:245
35. Natsuizaka M, Chiba H, Kuronuma K, Otsuka M, Kudo K, Mori M, et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 2014;190:773-9
36. Tsukamoto K, Chiba K, Hayakawa H, Sato A, Nakajima Y, Doi O. Prediction of outcome after acute exacerbation of idiopathic interstitial pneumonia. Jpn J Thorac Dis 1997;35:746-54
37. Takahashi T, Munakata M, Ohtsuka Y, Nasuhara Y, Kamoike A, Sato R. Effects of corticosteroid pulse treatment on outcomes in acute exacerbations of idiopathic interstitial pneumonia. Jpn J Thorac Dis 1997;35:9-15